Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (181468)

12/15/2021 5:52:31 PM

From: maceng2

Respond to of 217887

<< Its over Pfizers ivermectin cuts death by 90% in hospital covid patients Omcron, PFE, and the political stage have ended the pandemic unless they release a worse bug >>

No big surprise there at all. A proper evaluation of Ivermectine is shown in brief here.

•Statistically significant improvements are seen for mortality, ventilation, ICU admission, hospitalization, recovery, cases, and viral clearance. All remain significant after exclusions. 47 studies from 43 independent teams in 19 different countries show statistically significant improvements in isolation (36 primary outcome, 33 most serious outcome).
•Meta analysis using the most serious outcome shows 66% [53-76%] and 83% [73-89%] improvement for early treatment and prophylaxis, with similar results after exclusion based sensitivity analysis (excluding all GMK/BBC team studies), for primary outcomes, for peer-reviewed studies, and for RCTs.
•Results are very robust — in worst case exclusion sensitivity analysis 58 of 70 studies must be excluded to avoid finding statistically significant efficacy.
•While many treatments have some level of efficacy, they do not replace vaccines and other measures to avoid infection. Only 26% of ivermectin studies show zero events in the treatment arm.
• Multiple treatments are typically used in combination, which may be significantly more effective.
•Elimination of COVID-19 is a race against viral evolution. No treatment, vaccine, or intervention is 100% available and effective for all variants. All practical, effective, and safe means should be used, including treatments, as supported by Pfizer [ Pfizer, TrialSiteNews]. Denying the efficacy of treatments increases the risk of COVID-19 becoming endemic; and increases mortality, morbidity, and collateral damage.

	Studies	Prophylaxis	Early treatment	Late treatment	Patients	Authors
All studies	70	83% [73-89%]	66% [53-76%]	37% [23-49%]	49,938	669
Peer-reviewed	48	85% [74-92%]	70% [53-81%]	39% [19-54%]	17,913	496
With GMK/BBC exclusions	50	80% [66-89%]	73% [63-80%]	47% [26-62%]	37,998	545
Randomized Controlled Trials	31	84% [25-96%]	63% [44-75%]	23% [-1-41%]	6,858	358
RCTs w/GMK/BBC exclusions	27	84% [25-96%]	68% [53-78%]	25% [-2-44%]	4,583	330
Percentage improvement with ivermectin treatment

https://ivmmeta.com/

taken from the notes here

taken from the post here.
Message 33620215

The last few minutes of the utube video shows the 2015 Nobel Prize co winner inventor of Ivermectine latest works that Merk has decided to ignore.

Regarding Ivermectine and pfizers new Ivermectine's look alike drug. I am confident Reuters will be reporting. -g-